Bioasis and WuXi Biologics Announce Initial Strategic Collaboration for the Development and Manufacturing of xB3-001, the Company’s Lead Investigational Candidate to Treat Brain Cancer May 22, 2018 Life Science
WuXi Biologics Plans Another New CDMO Plant — A $240 Million Facility in Shijiazhuang May 17, 2018 Life Science
Life Science & Technology Weekly 143 – Meet this FDA Approved Medical Device Company that Is Making Big Moves into China’s Anesthetic Injections Market May 17, 2018 Cannabis, Life Science
HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders May 16, 2018 Life Science
Tonghua Dongbao Pharma Acquires Two Diabetes Treatments in $135 Million Deal May 15, 2018 Life Science
Chinese Scientist Is Elected to Select European Molecular Biology Organization May 15, 2018 Life Science
Changshan Biochemical Pharma Signs $9.5 Million Deal for Osteoarthritis Combo Drug May 14, 2018 Life Science
Chinese-French Institut Pasteur of Shanghai Achieves Impressive Medical Innovation Results May 14, 2018 Life Science
